Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 20/20 | 0.70 |
| ▸ | F3 | P13726 | 20/20 | 0.70 |
| ▸ | F2 | P00734 | 9/20 | 0.70 |
| ▸ | F10 | P00742 | 9/20 | 0.70 |
| ▸ | F11 | P03951 | 9/20 | 0.70 |
| ▸ | KLK1 | P06870 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2911371 | 1.00 | F7 (0.70) | F7F3F2F10F11 | |
| SCHEMBL2911374 | 1.00 | F7 (0.70) | F7F3F2F10F11 | |
| Trifluoroacetic Acid SCHEMBL2913963 | 0.97 | F7 (0.66) | F7F3F2F10F11 | |
| Trifluoroacetic Acid SCHEMBL2992812 | 0.97 | F7 (0.66) | F7F3F2F10F11 | |
| SCHEMBL2915342 | 0.96 | F7 (0.73) | F7F3F2F10F11 | |
| SCHEMBL2915337 | 0.96 | F7 (0.73) | F7F3F2F10F11 | |
| SCHEMBL2916381 | 0.96 | F7 (0.64) | F7F3F2F10F11 | |
| SCHEMBL2916397 | 0.96 | F7 (0.64) | F7F3F2F10F11 | |
| Trifluoroacetic Acid SCHEMBL4333617 | 0.93 | F7 (0.69) | F7F3F2F10F11 | |
| SCHEMBL2917443 | 0.92 | F7 (0.66) | F7F3F2F10F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622585-B2 | Phenylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-24 | — | — | US | claimed |
| US-7622585-B2 | Phenylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-24 | — | — | US | disclosed |